A comparative evaluation of adrenalectomy and androgen in advanced mammary carcinoma.
作者信息
DAO T L, TAN E
出版信息
Cancer Chemother Rep. 1962 Feb;16:309-15.
PMID:13883500
Abstract
摘要
相似文献
1
A comparative evaluation of adrenalectomy and androgen in advanced mammary carcinoma.
Cancer Chemother Rep. 1962 Feb;16:309-15.
2
Androgens in advanced cancer of the breast.
Cinci J Med. 1948 Oct;29(10):556-9.
3
[The treatment of advanced breast carcinoma with fluoxymesterone. Results of 43 personal cases].
Tumori. 1961 Nov-Dec;47:453-61.
4
[A new method of intraoperative hormone therapy in breast carcinoma].
Klin Med Osterr Z Wiss Prakt Med. 1962 Jan;17:49-62.
5
[The importance of tissue culture for hormone therapy in breast carcinoma].
Klin Med Osterr Z Wiss Prakt Med. 1962 Feb;17:83-9.
6
Antitumor efficacy of fluoxymesterone. Use in advanced breast cancer.
Arch Intern Med. 1961 Feb;107:241-4. doi: 10.1001/archinte.1961.03620020091008.
7
The use of androstan-3, 11, dione-17beta-hydroxy, 17-methyl (compound NSC 19605) in the treatment of advanced breast cancer.
Cancer. 1962 Mar-Apr;15:330-3. doi: 10.1002/1097-0142(196203/04)15:2<330::aid-cncr2820150215>3.0.co;2-n.
8
Fluoxymesterone ("halotestin"): a new androgen.
Med J Aust. 1959 Oct 3;46(2):468-70. doi: 10.5694/j.1326-5377.1959.tb129204.x.
9
Treatment of far-advanced inoperable carcinoma of the breast with estrogens and androgens.
J Clin Endocrinol Metab. 1948 Jul;8(7):585.
10
The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of 105 female patients.
J Am Med Assoc. 1949 Aug 13;140(15):1193-1200. doi: 10.1001/jama.1949.02900500001001.
Zotero 插件